Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion description "[Activating mutations in NOTCH1 are present in over 50% of human T-cell lymphoblastic leukemia (T-ALL) samples and inhibition of NOTCH1 signaling with gamma-secretase inhibitors (GSI) has emerged as a potential therapeutic strategy for the treatment of this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion evidence source_evidence_literature NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion SIO_000772 16688224 NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion wasDerivedFrom befree-20140225 NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_assertion wasGeneratedBy ECO_0000203 NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP737067.RA0hBLLyIOPcyH2Nzy_r7y1gk6APkjKOIMW6qxmf2KZJ4130_provenance.